0001062993-22-019753.txt : 20220920 0001062993-22-019753.hdr.sgml : 20220920 20220920065426 ACCESSION NUMBER: 0001062993-22-019753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220916 FILED AS OF DATE: 20220920 DATE AS OF CHANGE: 20220920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamilton Thomas Edward CENTRAL INDEX KEY: 0001769848 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 221252062 MAIL ADDRESS: STREET 1: 211 STUYVESANT AVE CITY: RYE STATE: NY ZIP: 10580 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-09-16 0001374690 Larimar Therapeutics, Inc. LRMR 0001769848 Hamilton Thomas Edward C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506 BALA CYNWYD PA 19004 1 0 0 0 Common Stock 2022-09-16 4 P 0 317460 3.15 A 507590 D Common Stock 159433 I FA Life Sciences, Inc. Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022. /s/ Jennifer Johansson, Attorney-in-fact 2022-09-20